Andrew Spencer

Andrew Spencer

UNVERIFIED PROFILE

Are you Andrew Spencer?   Register this Author

Register author
Andrew Spencer

Andrew Spencer

Publications by authors named "Andrew Spencer"

Are you Andrew Spencer?   Register this Author

100Publications

2385Reads

7Profile Views

Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).

Leuk Lymphoma 2019 Jun 11:1-9. Epub 2019 Jun 11.

a Myeloma Research Group, Australian Centre for Blood Diseases , Alfred Hospital/Monash University , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1571201DOI Listing
June 2019

Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients.

Cancers (Basel) 2019 Jun 25;11(6). Epub 2019 Jun 25.

Myeloma Research Group, Australian Centre for Blood Diseases (ACBD), Clinical Central School, Monash University, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11060887DOI Listing
June 2019

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.

Cancers (Basel) 2019 Jun 29;11(7). Epub 2019 Jun 29.

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne 3004, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11070917DOI Listing
June 2019

Psychometric properties of the Child Oral-care Performance Assessment Scale.

Community Dent Oral Epidemiol 2019 May 30. Epub 2019 May 30.

ARCPOH, Adelaide Dental School, University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12476DOI Listing
May 2019

Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.

Biomaterials 2019 Apr 4;198:78-94. Epub 2018 Aug 4.

Department of Chemical and Biomolecular Engineering, University of California- Los Angeles, Los Angeles, CA 90095, USA; Center for Minimally Invasive Therapeutics (C-MIT), University of California-Los Angeles, Los Angeles, CA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01429612183056
Publisher Site
http://dx.doi.org/10.1016/j.biomaterials.2018.08.010DOI Listing
April 2019

Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.

Clin Lymphoma Myeloma Leuk 2019 Apr 28. Epub 2019 Apr 28.

National University Cancer Institute, National University Health System, Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.04.011DOI Listing
April 2019

Analysis of Circulating Tumor DNA.

Methods Mol Biol 2018 ;1792:129-145

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7865-6_9DOI Listing
February 2019

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Br J Haematol 2019 Feb 20;184(4):536-546. Epub 2018 Nov 20.

Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15679DOI Listing
February 2019

DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.

Leuk Lymphoma 2018 12 4;59(12):2842-2846. Epub 2018 Apr 4.

a Department of Clinical Haematology , Alfred Health , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1454595DOI Listing
December 2018

-C-H arylation of fluoroarenes traceless directing group relay strategy.

Chem Sci 2018 Sep 25;9(35):7133-7137. Epub 2018 Jul 25.

School of Chemistry , University of Manchester , Oxford Road , Manchester , M13 9PL , UK . Email:

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C8SC02417K
Publisher Site
http://dx.doi.org/10.1039/c8sc02417kDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137440PMC
September 2018

Dental knowledge and dental service utilization: A 2-year follow-up study.

Community Dent Oral Epidemiol 2018 08 20;46(4):336-342. Epub 2018 Feb 20.

Australian Research Centre for Population Oral Health, Adelaide Dental School, The University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12371DOI Listing
August 2018

Critical review of the validity of patient satisfaction questionnaires pertaining to oral health care.

Community Dent Oral Epidemiol 2018 08 30;46(4):369-375. Epub 2018 Mar 30.

ARCPOH, Adelaide Dental School, University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cdoe.12377DOI Listing
August 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 Aug 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.

Int J Mol Sci 2018 Jun 24;19(7). Epub 2018 Jun 24.

Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital⁻Monash University, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms19071858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073672PMC
June 2018

Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.

Support Care Cancer 2018 Mar 11;26(3):947-955. Epub 2017 Oct 11.

Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3915-1DOI Listing
March 2018

Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges.

ACS Sens 2018 03 23;3(3):540-560. Epub 2018 Feb 23.

Myeloma Research Group, Australian Center for Blood Diseases , Monash University , Melbourne , Victoria 3004 , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acssensors.7b00953DOI Listing
March 2018

Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring.

Biol Blood Marrow Transplant 2017 Nov 7;23(11):1961-1967. Epub 2017 Aug 7.

The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.07.025DOI Listing
November 2017

Factors Influencing Early Feeding of Foods and Drinks Containing Free Sugars-A Birth Cohort Study.

Int J Environ Res Public Health 2017 10 23;14(10). Epub 2017 Oct 23.

School of Public Health, Curtin University, Perth, WA 6845, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijerph14101270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664771PMC
October 2017

Circulating tumour DNA analysis in multiple myeloma.

Oncotarget 2017 Oct 7;8(53):90610-90611. Epub 2017 Oct 7.

Andrew Spencer: Australian Centre for Blood Diseases, Monash University, Malignant Haematology & Stem Cell Transplantation, Alfred Hospital and Department of Clinical Haematology, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710860PMC
October 2017

β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma.

Mol Cancer Ther 2017 09 12;16(9):1765-1778. Epub 2017 May 12.

Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0624DOI Listing
September 2017

An Evidence-Based Approach to Myeloma Bone Disease.

Curr Hematol Malig Rep 2017 04;12(2):109-118

Department of Haematology, Alfred Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11899-017-0370-5
Publisher Site
http://dx.doi.org/10.1007/s11899-017-0370-5DOI Listing
April 2017

Myeloma in the Real World: What Is Really Happening?

Clin Lymphoma Myeloma Leuk 2017 03 26;17(3):133-144.e1. Epub 2016 Dec 26.

Alfred Health, Melbourne, Victoria, Australia; Central Clinical School, Monash University, The Alfred Centre, Melbourne, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.12.002DOI Listing
March 2017

Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.

Cancer Treat Rev 2016 Nov 30;50:200-204. Epub 2016 Sep 30.

Department of Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.09.014DOI Listing
November 2016

Epigenetic regulation of miRNA-124 and multiple downstream targets is associated with treatment response in myeloid malignancies.

Oncol Lett 2016 Sep 25;12(3):2175-2180. Epub 2016 Jul 25.

Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia; Translational Research Division, Eastern Clinical Research Unit, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria 3004, Australia; Department of Medicine, Eastern Health Clinical School, Monash University, Melbourne, Victoria 3128, Australia.

View Article

Download full-text PDF

Source
https://www.spandidos-publications.com/10.3892/ol.2016.4912
Publisher Site
http://dx.doi.org/10.3892/ol.2016.4912DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998575PMC
September 2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

N Engl J Med 2016 Aug;375(8):754-66

From the Department of Hematology, University of Turin, Turin, Italy (A.P.); the Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville (A.C.-K.); Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tuebingen (K.W.), and University Medical Center of the Johannes Gutenberg-University, Third Department of Medicine, Mainz (M.M.) - both in Germany; Winship Cancer Institute, Emory University, Atlanta (A.K.N.); the Department of Hematology and Stem Cell Transplantation, St. László Hospital, Semmelweis University, Budapest, Hungary (T.M.); Ankara University, Department of Hematology, Ankara, Turkey (M.B.); Clinical Department of Hematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic (I.S.); Irmandade Da Santa Casa De Misericordia De São Paulo, São Paulo (V.H.); University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain (M.V.M.); Weill Cornell Medical College, New York (T.M.M.); Janssen Research and Development, Spring House, PA (M.Q., X.Q., T.A.); Janssen Research and Development, Raritan, NJ (J.S., H.A.); Janssen Research and Development, Beerse, Belgium (W.D.); Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia (A.S.); and the Department of Hematology, Erasmus MC, Rotterdam, the Netherlands (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606038DOI Listing
August 2016

Myeloma of the central nervous system - an ongoing conundrum!

Leuk Lymphoma 2016 07 21;57(7):1505-6. Epub 2016 Mar 21.

c St Vincent's Hospital , Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1154961DOI Listing
July 2016

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Cancer Biol Med 2016 Jun;13(2):215-25

Myeloma Research Group, Australian Center for Blood Diseases, Monash University, Melbourne 3004, Australia; Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944540PMC
June 2016

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.

J Antimicrob Chemother 2016 Feb 30;71(2):497-505. Epub 2015 Oct 30.

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

View Article

Download full-text PDF

Source
http://jac.oxfordjournals.org/content/early/2015/10/29/jac.d
Web Search
http://www.jac.oxfordjournals.org/lookup/doi/10.1093/jac/dkv
Publisher Site
http://dx.doi.org/10.1093/jac/dkv343DOI Listing
February 2016

Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management.

Curr Opin Nephrol Hypertens 2015 Sep;24(5):410-6

aArdelyx, Inc., Fremont, California, USA bAstraZeneca Research and Development, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNH.0000000000000154DOI Listing
September 2015

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

J Clin Oncol 2015 Sep 3;33(26):2863-9. Epub 2015 Aug 3.

Antonio Palumbo, Stefania Oliva, Simona Caltagirone, Sara Bringhen, and Francesca Gay, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute della Salute e della Scienza di Torino; Roberto Passera, University of Torino, Torino; Massimo Offidani, Clinica di Ematologia, AUO Ospedali Riuniti di Ancona, Ancona; Pellegrino Musto, Istituto di Ricovero e Cura a Carattere Scientifico, Referral Cancer Center of Basilicata, Rionero in Vulture; Maria T. Petrucci, Sapienza University of Rome, Rome; Elena Zamagni and Michele Cavo, Istituto di Ematologia Seragnoli, Università di Bologna, Bologna, Italy; Hervé Avet-Loiseau and Michel Attal, Institut Claudius Regaud, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse; Thierry Facon, Service des Maladies du Sang, Hôpital Claude Huriez, Centre Hospitalier Regionale et Universitaire Lille, Lille; Philippe Moreau, University Hospital Hotel-Dieu, Nantes, France; Henk M. Lokhorst, VU University Medical Center, Amsterdam; Pieter Sonneveld, Erasmus MC, Rotterdam, the Netherlands; Hartmut Goldschmidt, University Hospital and National Center for Tumor Diseases Heidelberg, Heidelberg, Germany; Laura Rosinol, Hospital Clínic, Institut Clínic d'Investigacions Biomèdiques Ausgust Pi i Sunyer, Barcelona; Juan José Lahuerta, Hospital Universitario 12 de Octubre, Madrid; Jésus San Miguel, Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas, IDISNA, Pamplona, Spain; Paul Richardson and Kenneth C. Anderson, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA; Shaji Kumar and S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; Sagar Lonial, Winship Cancer Institute, Emory University, Atlanta, GA; Robert Z. Orlowski, The University of Texas MD Anderson Comprehensive Cancer Center, Houston, TX; Gareth Morgan, Myeloma Institutes for Research Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; Brian G.M. Durie, Cedars-Sinai Comprehensive Canc

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/03/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.2267
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.2267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846284PMC
September 2015

Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma".

Haematologica 2015 Sep;100(9):e379

Peter MacCallum Cancer Centre, East Melbourne, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.128470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800680PMC
September 2015

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

N Engl J Med 2015 Aug 2;373(7):621-31. Epub 2015 Jun 2.

From Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.L.); National and Kapodistrian University of Athens, Athens (M.D.); A.O.U. San Giovanni Battista di Torino-Ospedale Molinette, Turin, Italy (A.P.); QEII Health Science Center and Dalhousie University, Halifax, NS (D.W.), Cross Cancer Institute and University of Alberta, Edmonton (A.B.), and Princess Margaret Cancer Centre, Toronto (D.R.) - all in Canada; Silesian Medical University, Katowice (S.G.), and Medical University of Lublin, Lublin (A.W.-C.) - both in Poland; Charles University Hospital, Prague, Czech Republic (I.S.); University Hospital, Nantes, France (P.M.); Complejo Asistencial Universitario de Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca (M.-V.M.), and Clinica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Pamplona (J.S.-M.) - both in Spain; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, and Tel Aviv University, Ramat Aviv - both in Israel (H.M.); Ankara University, Ankara, Turkey (M.B.); Alfred Health-Monash University, Melbourne, VIC, Australia (A. Spencer); Barts and the London NHS Trust, London (H.O.); University of Texas M.D. Anderson Cancer Center, Houston (R.Z.O.); Kyoto Prefectural University of Medicine, Kyoto (M.T.), and Nishigunma National Hospital, Shibukawa (M.M.) - both in Japan; Universitätsklinikum der Technische Universität, Dresden (C.R.), and Universitätsklinikum Würzburg, Würzburg (H.E.) - both in Germany; Zeikenhuis Netwerk Antwerpen (ZNA) Stuivenberg, Antwerp, Belgium (K.L.W.); AbbVie Biotherapeutics, Redwood City, CA (A. Singhal); Bristol-Myers Squibb, Princeton, NJ (J.K.), Wallingford, CT (E.B.), and Braine-l'Alleud, Belgium (V.P.); and Dana-Farber Cancer Institute, Boston (K.C.A., P.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1505654DOI Listing
August 2015

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Am J Hematol 2015 May 27;90(5):E86-91. Epub 2015 Feb 27.

Peter MacCallum Cancer Centre, East Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23967DOI Listing
May 2015

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia.

Br J Haematol 2015 Apr 2;169(2):199-210. Epub 2015 Feb 2.

Department of Clinical Haematology, The Alfred Hospital, Melbourne, Vic., Australia; The Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13281DOI Listing
April 2015

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Haematologica 2015 Feb 7;100(2):e60-2. Epub 2014 Nov 7.

Alfred Hospital, Myeloma Research Group, Australian Centre for Blood Diseases, Monash University, Melbourne

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.111385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803129PMC
February 2015

Comparison of the probability of target attainment of anidulafungin against Candida spp. in patients with acute leukaemia.

Int J Antimicrob Agents 2014 Nov 6;44(5):450-7. Epub 2014 Sep 6.

Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2014.07.019DOI Listing
November 2014

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Epigenetics 2014 Nov;9(11):1511-20

a Myeloma Research Group; Division of Blood Cancers; Australian Center for Blood Diseases; Alfred Hospital; Monash University ; Melbourne , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/15592294.2014.983367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622977PMC
November 2014

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.

Clin Cancer Res 2014 Feb 2;20(3):724-35. Epub 2013 Dec 2.

Authors' Affiliations: Department of Immunology, Central Clinical School; and Department of Clinical Hematology, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1576DOI Listing
February 2014

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.

J Clin Oncol 2014 Feb 13;32(6):587-600. Epub 2014 Jan 13.

Antonio Palumbo and Alessandra Larocca, University of Torino, Torino; Michele Cavo, Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy; S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; Jesus F. San Miguel, University Hospital of Salamanca, Salamanca, Spain; Ruben Niesvizky, Weill Cornell Medical College, New York, NY; Gareth Morgan, Royal Marsden Hospital, London, United Kingdom; Ola Landgren, National Cancer Institute, Bethesda, MD; Roman Hajek, University of Ostrava School of Medicine and University Hospital Ostrava, Ostrava, Czech Republic; Hermann Einsele, University of Wurzburg, Wurzburg, Germany; Kenneth C. Anderson and Paul G. Richardson, Dana-Farber Cancer Institute, Boston, MA; Meletios A. Dimopoulos, University of Athens School of Medicine, Athens, Greece; Andrew Spencer, Alfred Hospital, Melbourne, Victoria, Australia; A. Keith Stewart, Mayo Clinic, Scottsdale, AZ; Kazuyuki Shimizu, Aichi Gakuin Hospital, Nagoya, Japan; Sagar Lonial, Emory University, Atlanta, GA; Pieter Sonneveld, Erasmus Medical Centre, Rotterdam, the Netherlands; Brian G.M. Durie, Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA; Philippe Moreau, University Hospital, Nantes, France; and Robert Z. Orlowski, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/32/6/587.full.pdf
Web Search
https://myeloma.org/pdfs/IMWG_Pub/2014%20JCO-%20Palumbo-%20I
Web Search
http://szpiczak.org/lang/aktualnosci/publikacje/rok_2013/LUD
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.48.7934
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.48.7934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918540PMC
February 2014

Modeling multiple-frequency electron cyclotron resonance heating.

Rev Sci Instrum 2014 Feb;85(2):02A914

FAR-TECH, Inc., San Diego, California 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.4827540DOI Listing
February 2014

A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia.

Clin Lymphoma Myeloma Leuk 2013 Oct 15;13(5):575-8. Epub 2013 Jun 15.

Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Haematology, Nottingham City Hospital, Hucknall Road, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.04.006DOI Listing
October 2013

Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.

Br J Haematol 2013 Aug 29;162(3):371-5. Epub 2013 May 29.

Malignant Haematology and Stem cell Transplantation Service, The Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12404DOI Listing
August 2013

Findings and patterns on MRI and MR spectroscopy in neonates after therapeutic hypothermia for hypoxic ischemic encephalopathy treatment.

South Med J 2013 Jun;106(6):350-5

University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SMJ.0b013e3182967d38DOI Listing
June 2013

Is clinical oral health poorer in regional areas compared with major city areas?

Aust J Rural Health 2013 Jun;21(3):150-7

Australian Research Centre for Population Oral Health, School of Dentistry, The University of Adelaide, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajr.12034DOI Listing
June 2013

Lenalidomide in multiple myeloma: Current status and future potential.

Am J Hematol 2012 Dec 28;87(12):1089-95. Epub 2012 May 28.

Myeloma Research Group, Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23234
Publisher Site
http://dx.doi.org/10.1002/ajh.23234DOI Listing
December 2012

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.

Br J Haematol 2012 Oct 4;159(1):58-66. Epub 2012 Aug 4.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09251.xDOI Listing
October 2012